Date of Conferral
6-10-2024
Date of Award
June 2024
Degree
Ph.D.
School
Public Health
Advisor
Howell Sasser
Abstract
Racial minority U.S. populations are underrepresented in clinical trials. Ensuring people from diverse backgrounds join clinical trials is key to advancing health equity. Participants in clinical trials should represent the patients’ population. The purpose of this quantitative study was to assess the association of individual-level factors (age, sex, marital status, family history of Alzheimer’s disease, living arrangement), health-related factors (smoking and alcohol), and socioeconomic status (years of education, employment status, health insurance status) and the interest in clinical trial participation among African Americans (AAs). The theoretical foundation that grounded this study was the health belief model. Secondary data from 214 AAs were used to evaluate the association between the independent variables and the dependent variable of interest in clinical trial participation among AAs. Results of multiple regression analyses indicated the independent variables were not statistically significant in predicting AAs’ interest in clinical trial participation. Results may be used by public health professionals and clinical researchers to improve clinical trial recruitment and participation among racial and ethnic minorities.
Recommended Citation
AWOSIKA-OLUMO, Morounsayo Abimbola, "Factors Affecting African Americans’ Participation in Alzheimer’s Disease Clinical Trials" (2024). Walden Dissertations and Doctoral Studies. 16182.
https://scholarworks.waldenu.edu/dissertations/16182
